Bronchoscopes Market

Market Overview

The global bronchoscopes market size was valued at USD 2.71 billion in 2022. It is projected to reach USD 6.28 billion by 2031, growing at a CAGR of 9.8% during the forecast period (2023–2031). 

Bronchoscopes assess and treat many respiratory and airway diseases. Doctors use bronchoscopes to examine airways. Bronchoscopes are thread-like devices that pass through the nose or mouth to the lungs. Rigid and flexible bronchoscopes dominate. These devices can detect blockages, COPD, bronchopulmonary hemorrhage, tumors, airway stenosis, and inflammatory conditions. Diagnostic and therapeutic bronchoscopes study the lungs. Bronchoscopes are introduced through the mouth or nose and occasionally through tracheostomy to view distal bronchial branches. Bronchoscopy usually uses a flexible bronchoscope. In cases of blood in the lungs or a large object in the airway, a stiff bronchoscope may be needed. Bronchoscopes examine the lungs' inner airways.

The equipment is inserted through the mouth, nose, or tracheostomy. This helps the doctor identify foreign bodies, hemorrhage, tumors, and airway inflammation. Bronchoscopes can diagnose and perform airway surgery. Bronchoscopes range from rigid metal tubes with lighting to flexible optical fiber devices with real-time video. Reusable or single-use bronchoscopes can perform bronchoscopy. Reusable and disposable bronchoscopes depend on use. Single-use or reusable endoscopes are used for lung and tracheobronchial tree diagnosis and treatment. Single-use bronchoscopes can detect lung infections, COPD, tumors, lung disease, bronchial stenosis, pneumonia, and bronchitis. Reusable bronchoscopes can treat multiple patients. These devices must be cleaned and sterilized between uses.

Market Dynamics

Market Drivers

Increase in Respiratory Diseases and Geriatric Population

Chronic respiratory diseases affect lung structures and airways. It reduces lung function in all ages. Early diagnosis and treatment can improve health and prevent premature death. CRDs are incurable, but treatment can manage symptoms and improve quality of life. Due to high disease incidence and complications, elderly patients should be diagnosed and treated immediately. Assessment was done for flexible bronchoscopy (FB) findings and its diagnostic value in patients 65 and older. Chronic Respiratory Diseases are a major global health issue. Our weekly outpatient clinics treat chronic lung diseases and unexplained respiratory issues. Experienced respiratory consultants diagnose and refer patients quickly.

Technological Innovations in Bronchoscopy Devices

Many advances in advanced bronchoscopy diagnostics are exciting. Pulmonologists used to refer patients to radiologists, surgeons, and medical oncologists instead of bronchoscopic approaches. This is due to technology, standards, demand, and the bronchoscopy ecosystem. More innovations are coming. Such advances allow respiratory therapists (RTs) to contribute clinical, organizational, and scientific expertise to this evolving space. Real-time ultrasound, peripheral navigation, and newer bronchoscopes have improved diagnostic bronchoscopy. Real-time visualization has improved bronchoscopists' biopsies while avoiding vascular structures. Bronchoscopes can only enter third- and fourth-generation airways. This challenge limits advanced bronchoscopy yields, except for ultrasound for proximal lesions. Slimmer bronchoscopes with larger working channels, more angulation, better imaging, and pathological assessment at visualization are now available.

Market Restraints

Post Bronchoscopy Infection and Cross-Contamination Risk

Bronchoscopes must be reprocessed between patients to remove soil and contaminants and disinfect or sterilize microorganisms. Reprocessing cleans, disinfects, and sterilizes reusable devices. If not properly cleaned, the flexible bronchoscope can spread infection from patient to patient. Use without pre-cleaning. Pre-cleaning involves surface wiping and channel flushing to prevent blood, tissue, and other biological debris from drying; Insufficient manual cleaning before HLD or sterilization; Channels not cleaned; expired detergent or high-level disinfectant; Insufficient HLD flushing, rinsing, and drying. This situation leads to the cross-contamination of diseases and infections in patients and restraints the growth of market.

Market Opportunity

Initiatives By Developing Country Governments

Market growth may result from government healthcare spending and reimbursement system development. As respiratory disorders rise, bronchoscope demand rises. Over 64 million people have COPD, 3 million have died from it, and 1.8 million have lung cancer, according to the WHO. Air pollution causes many respiratory issues that affect our health, so respiratory wellness is crucial. Poor air quality causes emphysema, allergies, respiratory infections, asthma, and COPD. The WHO recently declared air pollution “the single largest environmental threat to human health and well-being.”

Regional Analysis

Asia Pacific Dominates the Global Market.

The global bronchoscopes market is bifurcated into four regions: North America, Europe, Asia-Pacific, and LAMEA.

Asia Pacific is expected to grow at a fastest CAGR of 10.32% during the forecast period. China, India, Japan, Australia, and the rest of Asia-Pacific are all included in the analysis of the Asia-Pacific market. Mandatory healthcare insurance, rising technology, rising healthcare expenditure, and an increasing number of global companies looking to meet high unmet medical needs in these countries are driving the market. India is expected to hold 19.5% of the Asia Pacific bronchoscopes market by value and grow. Indian bronchoscope demand is driven by chronic pulmonary diseases, government healthcare spending, and bronchoscopy adoption.

North America is the most significant shareholder in the global bronchoscopes market and is expected to grow at a CAGR of 9.2% during the forecast period. The U.S. and Canada are included in the analysis of the market in North America. Due to factors like an increase in hospitals, healthcare infrastructure, healthcare spending, an aging population, and a large patient population, the U.S. is expected to hold 91.8% market share by value in North America. Bronchoscope demand is also rising due to favorable U.S. reimbursement scenarios, which is expected to continue. North America leads the market due to rising lung cancer rates and a large number of well-established market players. The U.S. is the biggest bronchoscope market.

Segmental Analysis

The market is segmented by product, usability, application, and end user.

Based on the product, the global market is bifurcated into rigid bronchoscopes and flexible bronchoscopes.

The flexible bronchoscopes segment is the highest contributor to the market and is expected to grow at a CAGR of 9.54% during the forecast period. Video, fiberoptic, and hybrid flexible bronchoscopes exist. Due to high video quality and cost-effectiveness, the flexible segment had the most revenue. Due to its many benefits, such as high-quality videos that make tumors and infections in deeper bronchioles easy to identify, the fiberoptic sub-segment has dominated the flexible segment. Flexible bronchoscopes also benefit doctors and patients. Flexible bronchoscopy recovers faster than rigid. These narrow devices can reach deeper into small lumens.

Based on usability, the global bronchoscopes market is bifurcated into reusable and disposable.

The reusable segment is the highest contributor to the market and is expected to grow at a CAGR of 9.63% during the forecast period. Reprocessing between uses removes soil and contaminants and sterilizes or disinfects microorganisms. Given the risk of viral transmission when using reusable flexible bronchoscopes, various professional pulmonary societies have issued guidelines for using single-use flexible bronchoscopes (SUFB) during the ongoing pandemic. Single Use Bronchoscopes are portable, accessible, and may be cheaper than RFB for treating bronchoscopy-related infections. Due to their maneuverability, handling, angle of deflection, image quality, and larger channel size for passing ancillary instruments, reusable flexible bronchoscopes are still used for advanced diagnostic and therapeutic procedures.

Based on application, the global bronchoscopes market is bifurcated into diagnosis and treatments.

The diagnosis segment is the highest contributor to the market and is expected to grow at a CAGR of 10.1% during the forecast period. Bronchoscopy diagnoses lung diseases. A flexible or rigid tube is guided into your bronchial tubes and lungs through your nose or mouth. The tube has a camera and surgical tools to remove growths. The doctor will check for lung disorders after inserting the tube. Bronchoscopy shows the vocal cords, trachea, large proximal airways, and smaller distal airways to the third or fourth generation. FOB samples and treats airway lesions and lung parenchyma.

Based on end-user, the global is bifurcated into hospitals, clinics, ambulatory surgical centers, and others.

The hospital segment is the highest contributor to the market and is expected to grow at a CAGR of 9.36% during the forecast period. You'll be numbed. This prevents gagging during bronchoscopy. Spray may taste bitter. The gagging will stop after the tube goes down. The doctor inserts the bronchoscope into your airways. Mild pain may occur. No airway obstruction. Breathe around the bronchoscope. If needed, you'll receive oxygen. Examine the lungs as the bronchoscope descends. Testing may involve tissue or mucus. Other methods may be used. Medicine or stopping bleeding are examples. As bronchoscopy needs various serious measures to be taken before the endoscopy patients prefers to go to hospitals for these surgeries. Other major reason for hospital segment to lead is the skilled staff present to do the bronchoscopy.

Recent Developments

• August 2022, Boston Scientific Corporation, announced FDA 510(k) clearance of the EXALTTM Model B Single-Use Bronchoscope for bedside ICU and OR procedures (OR).

• May 2022, Olympus Corporation, Japanese optics and reprography manufacturer signed a group purchasing agreement with Premier, Inc. in the Single-Use Visualization Devices category for their single-use bronchoscope portfolio.